PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Applied Health Research, University of Birmingham, Birmingham, UK.\', \'Cegedim Health Data, Cegedim Rx, London, UK.\', \'The Health Improvement Network (THIN), London, UK.\', \'Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.\', \'Department of Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.\', \'Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.\', \'Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.\', \'Centre for Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham Health Partners, Birmingham, UK.\', \'Department of Community and Family Medicine, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka.\', \'Diabetes Research Centre, University of Leicester, Leicester.\', \'Department of Diabetes, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'Midlands Health Data Research UK, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1210/clinem/dgab067
?:doi
?:hasPublicationType
?:journal
  • The Journal of clinical endocrinology and metabolism
is ?:pmid of
?:pmid
?:pmid
  • 33560344
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all